Columbus Circle Investors’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$18.4M Sell
202,279
-41,458
-17% -$2.57M 0.81% 41
2020
Q3
$9.74M Sell
243,737
-27,578
-10% -$963K 0.42% 87
2020
Q2
$9.31M Buy
271,315
+236,065
+670% +$7.04M 0.37% 91
2020
Q1
$783K Sell
35,250
-250
-0.7% -$6.32K 0.04% 138
2019
Q4
$695K Sell
35,500
-48,605
-58% -$772K 0.03% 145
2019
Q3
$1.31M Sell
84,105
-31,427
-27% -$602K 0.05% 138
2019
Q2
$2.35M Buy
115,532
+9,872
+9% +$178K 0.06% 136
2019
Q1
$1.86M Sell
105,660
-96,066
-48% -$1.52M 0.05% 131
2018
Q4
$2.59M Sell
201,726
-108,893
-35% -$1.52M 0.07% 129
2018
Q3
$5.06M Buy
310,619
+51,406
+20% +$608K 0.1% 151
2018
Q2
$2.94M Buy
259,213
+36,655
+16% +$404K 0.06% 175
2018
Q1
$2.17M Buy
+222,558
New +$2.13M 0.04% 177

Other funds holding FATE